Major factors in the morbidity and mortality of malignant melanoma are tumor invasion and metastasis, which are mediated by Matrix Metalloproteinases (MMPs). MMPs degrade the extracellular matrix, and are associated with invasive cancers. Degradation of interstitial collagens (types I and III) is needed for invasion, and is accomplished by the ubiquitously expressed collagenase-1 (MMP-1). A single nucleotide polymorphism (SNP; 2G allele) at -1607 bp (5'-GGAA-3') in the MMP-1 promoter creates a binding site for the Ets family of transcription factors and, compared to the 1G allele (5'-GAA-3'), enhances MMP-1 transcription. This 2G SNP is associated with the incidence/progression of seven malignancies, including melanoma. Levels of Basic Fibroblast Growth Factor (bFGF) correlate with invasive melanoma, and bFGF induces MMP-1 expression. In addition, an activating mutation in BRAF found in 80% of melanomas in the signaling cascade of Ras/Raf/Mek/Erk also induces MMP-1. We hypothesize that: (a) the 2G allele increases MMP-1 expression and melanoma invasion, (b) bFGF and the activating mutation in BRAF orchestrate an invasive phenotype in the tumor cells by preferentially increasing MMP-1 expression through the 2G allele, and (c) host/tumor/matrix interactions target the 2G allele in stromal cells adjacent to the tumor to further enhance MMP-1 expression and tumor invasion. We will, therefore, (1) Generate transgenic mice harboring 4 kb of the human MMP-1 promoter, containing either 1G or 2Gs at -1607 bp, linked to the beta-galactosidase reporter. Transgenes will be inserted as a single copy at the hprt locus to provide information on the transcriptional activity of MMP-1 in stromal cells. Mice will be challenged with B16 melanoma and expression of the transgenes, which reflects collagenolytic potential, will be examined in stromal cells adjacent to the tumor; (2) Convert a diploid 1G homozygous melanoma cell line to 2G homozygous, and conversely, a diploid 2G homozygous melanoma cell line to 1G homozygous, to compare effects of the 1G and 2G alleles on MMP-1 promoter and enzyme activities, and on tumor invasion in vitro and in vivo in nude mice. We will determine how bFGF and mutant BRAF target the 2G allele to enhance the invasive phenotype of melanoma cells. These studies will provide novel mechanisms for studying MMP-1 gene expression in mouse models, and contribute to our understanding of how this human interstitial collagenase contributes to the pathology of invasive melanoma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA077267-07
Application #
7214059
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Snyderwine, Elizabeth G
Project Start
1998-12-15
Project End
2008-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
7
Fiscal Year
2007
Total Cost
$238,793
Indirect Cost
Name
Dartmouth College
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Brinckerhoff, Constance E (2017) Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire? J Cell Physiol 232:2674-2678
Brinckerhoff, Constance E (2016) What are the therapeutic implications of increased collagen expression in melanoma cells treated with vemurafenib? Melanoma Manag 3:5-8
Jenkins, Molly H; Croteau, Walburga; Mullins, David W et al. (2015) The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells. Matrix Biol 48:66-77
Whipple, Chery A (2015) Tumor talk: understanding the conversation between the tumor and its microenvironment. Cancer Cell Microenviron 2:e773
Jenkins, Molly H; Steinberg, Shannon M; Alexander, Matthew P et al. (2014) Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032. Pigment Cell Melanoma Res 27:495-501
Whipple, C A; Brinckerhoff, C E (2014) BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity. Br J Cancer 111:1625-33
Croteau, Walburga; Jenkins, Molly H; Ye, Siying et al. (2013) Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma. J Cell Physiol 228:773-80
Schmucker, Adam C; Wright, Jason B; Cole, Michael D et al. (2012) Distal interleukin-1? (IL-1?) response element of human matrix metalloproteinase-13 (MMP-13) binds activator protein 1 (AP-1) transcription factors and regulates gene expression. J Biol Chem 287:1189-97
Zhou, Jing; Brinckerhoff, Constance; Lubert, Susan et al. (2011) Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors. Cancer Invest 29:599-607
Blackburn, J S; Liu, I; Coon, C I et al. (2009) A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene 28:4237-48

Showing the most recent 10 out of 33 publications